These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8094363)

  • 1. Factor XIIIA subunit and Crohn's disease.
    Hudson M; Wakefield AJ; Hutton RA; Sankey EA; Dhillon AP; More L; Sim R; Pounder RE
    Gut; 1993 Jan; 34(1):75-9. PubMed ID: 8094363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of diminished factor XIII in Crohn's disease.
    Chamouard P; Grunebaum L; Wiesel ML; Sibilia J; Coumaros G; Wittersheim C; Baumann R; Cazenave JP
    Am J Gastroenterol; 1998 Apr; 93(4):610-4. PubMed ID: 9576457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminases in Crohn's disease.
    D'Argenio G; Biancone L; Cosenza V; Della Valle N; D'Armiento FP; Boirivant M; Pallone F; Mazzacca G
    Gut; 1995 Nov; 37(5):690-5. PubMed ID: 8549947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease.
    Higaki S; Nakano K; Onaka S; Amano A; Tanioka Y; Harada K; Hashimoto S; Sakaida I; Okita K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1407-11. PubMed ID: 16911684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of blood coagulation factor XIII in Crohn's disease.
    Oshitani N; Kitano A; Hara J; Suzuki N; Aoki T; Yasuda K; Watanabe Y; Obayashi M; Obata A; Nakamura S
    Am J Gastroenterol; 1995 Jul; 90(7):1116-8. PubMed ID: 7611208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease.
    More L; Sim R; Hudson M; Dhillon AP; Pounder R; Wakefield AJ
    J Clin Pathol; 1993 Aug; 46(8):703-8. PubMed ID: 8408693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of ELISAs for factor XIIIA and XIIIB subunits in plasma.
    Murdock PJ; Owens DL; Chitolie A; Hutton RA; Lee CA
    Thromb Res; 1992 Jul; 67(1):73-9. PubMed ID: 1359667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of nuclear factor kappa B in Crohn's disease.
    Ellis RD; Goodlad JR; Limb GA; Powell JJ; Thompson RP; Punchard NA
    Inflamm Res; 1998 Nov; 47(11):440-5. PubMed ID: 9865503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
    Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
    Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole gut lavage fluid interleukin-1beta and interleukin-8 in smokers and non-smokers with Crohn's disease in clinical remission.
    Arnott ID; Williams N; Drummond HE; Ghosh S
    Dig Liver Dis; 2002 Jun; 34(6):424-9. PubMed ID: 12132790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor XIIIA and clot strength after cardiopulmonary bypass.
    Chandler WL; Patel MA; Gravelle L; Soltow LO; Lewis K; Bishop PD; Spiess BD
    Blood Coagul Fibrinolysis; 2001 Mar; 12(2):101-8. PubMed ID: 11302471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostasis in Crohn's disease: low factor XIII levels in active disease.
    Wisén O; Gardlund B
    Scand J Gastroenterol; 1988 Oct; 23(8):961-6. PubMed ID: 3201134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory cells in Crohn's disease of the terminal ileum.
    Sarsfield P; Jones DB; Wright DH
    Histopathology; 1996 Mar; 28(3):213-9. PubMed ID: 8729039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mean platelet volume (MPV) in Crohn's disease patients].
    Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
    Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse.
    Yamamoto T; Umegae S; Kitagawa T; Matsumoto K
    Aliment Pharmacol Ther; 2004 Mar; 19(6):671-8. PubMed ID: 15023169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor acetylhydrolase activity in intestinal mucosa and plasma of patients with Crohn's disease.
    Kald B; Smedh K; Olaison G; Sjödahl R; Tagesson C
    Digestion; 1996; 57(6):472-7. PubMed ID: 8913710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum calprotectin as a biomarker for Crohn's disease.
    Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
    J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS; Burnett DA; Markin RS; Vaughan WP
    Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.